ADC Review / Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international publication combining professional social media with an online-only, hybrid open-access, peer reviewed journal. The Journal is designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, (basic, translational and clinical) research, clinicians/physicians, along with regulatory affairs, government authorities and representatives from payers, and policy makers.
The Antibody Society is a non-profit association representing individuals and organizations involved in antibody research and development. We engage in activities that broadly benefit our members, such as education and publishing, and encourage collaboration between companies, academia and government organizations. We also help to organize conferences and networking events. As a trade association, the Society engages with government and international agencies to discuss issues of importance to the antibody community.
Bentham Science Publishers is a publishing company of scientific, technical, and medical literature based at Sharjah. Bentham publishes more than 116 subscription-based academic journals and over 230 open access journals and e-books.
Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications.
MabDesign is a French membership organization that aims to structure, mobilize and support the development of the French industrial sector in the field of therapeutic antibody and immunotherapy.
MabDesign provides strategic leverage and development opportunities for its members.
Medical News Today has established itself as a market leader for medical news, providing concise and accurate information that stands out in the ocean of content that is health on the internet. The content is targeted to an educated audience of both healthcare professionals and patients.
PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
Technology Networks Group is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas.
Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.